| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/29/2008 | US20080125351 Forming water-in-oil emulsion from aqueous phase (water soluble polypeptide and sugar) and oil phase comprising glycolic acid-lactic acid copolymer and solvent, adding silicone oil, hardening, drying; optimizing the silicone oil to polymer ratio to improve bioavailability of peptide drug |
| 05/29/2008 | US20080125350 Branched polyalkylene glycols |
| 05/29/2008 | US20080125349 Biocompatible polymer such as glycolic acid-lactic acid copolymer having dispersed therein a polypeptide and a sugar, for release of said peptide such as exendin-4 |
| 05/29/2008 | US20080125348 Biocompatible glycolic acid-lactic acid copolymer with a polypeptide and a sugar; drug delivery of peptide drugs such as exendin-4; improves bioavailability, patient compliance |
| 05/29/2008 | US20080125347 Use of host cells in forming modified target molecules, including therapeutic molecules having non-natural amino acids in their sequence; biosynthesis; drug conjugates |
| 05/29/2008 | US20080125346 Infant Formula |
| 05/29/2008 | US20080124758 Transmembrane domain removed recombinant human tyrosinase and method of producing the same |
| 05/29/2008 | US20080124743 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (u1) |
| 05/29/2008 | US20080124702 Methods of diagnosing cervical cancer |
| 05/29/2008 | US20080124402 N-(Pyridin-3-Yl)-2-Phenylbutanamides As Androgen Receptor Modulators |
| 05/29/2008 | US20080124401 Method of treating endothelial injury |
| 05/29/2008 | US20080124396 polymer synthesized by a cross-coupling reaction of polymer scaffold units and xenoantigens |
| 05/29/2008 | US20080124380 Contacting male ejaculate, prior to contact with a female egg, with an effective anti-fertility amount of a pharmaceutical composition, which comprises an antibody that binds a surface exposed epitope of SP22, and a pharmaceutically acceptable carrier |
| 05/29/2008 | US20080124374 Decellularized bone marrow extracellular matrix |
| 05/29/2008 | US20080124366 Methods and Compositions for Treating Tumors |
| 05/29/2008 | US20080124358 Chemically conjugating a peptide of interest to a heterologous peptide that has been expressed on the coat protein of a cowpea mosaic virus to generate a conjugate and administering the conjugate to a host animal to increase the level of TH1-type immune response |
| 05/29/2008 | US20080124354 Her-2 protein fragments, recombinant peptides comprising same, nucleotide molecules encoding same, recombinant vaccine vectors and immunogenic compositions comprising same, and methods for inducing immune response and treating cancer, comprising same |
| 05/29/2008 | US20080124353 Proteinase k resistant surface protein of neisseria meningitidis |
| 05/29/2008 | US20080124351 Proteinase k resistant surface protein of neisseria meningitidis |
| 05/29/2008 | US20080124346 Chimeric metal binding protein for use in prevention and treatment of cancer, diabetes, cardiovascular disease, obesity, metabolic disease, neurodegenerative disease, gastrointestinal disease, autoimmune disease, rheumatological disease and infectious disease. |
| 05/29/2008 | US20080124338 Using mixture comprising immunoglobulin and terminal region of nuclear factor kappa beta as therapeutic tool in treatment of sexually transmitted, ocular, cancer and atherosclerotic disorders |
| 05/29/2008 | US20080124337 Immunoglobulin for use in diagnosis, prevention and treatment of neisserial infection; immunootherapeutics |
| 05/29/2008 | US20080124336 Molecules and Methods for Inhibiting Shedding of KIM-1 |
| 05/29/2008 | US20080124335 Novel Polypeptide and the Use Thereof |
| 05/29/2008 | US20080124329 Conditioned Cell Immunization |
| 05/29/2008 | US20080124322 Activation and inhibition of the immune system |
| 05/29/2008 | US20080124320 High mobility group box (HMGB) protein which inhibits proinflammatory cytokine cascade for use in prevention and/or treatment of weight loss/obesity disorders |
| 05/29/2008 | US20080124316 Use of hyaluronidase for prevention and treatment of cardiovascular diseases |
| 05/29/2008 | US20080124315 Method of reducing CRF receptor mRNA |
| 05/29/2008 | US20080124314 Peptide inhibitors of cyclin-dependent kinase activity and uses thereof |
| 05/29/2008 | US20080124313 Nucleotide sequences coding methionyl tRNA synthetase protein for use in identifying modulators for prevention and treatment of bacterial infection |
| 05/29/2008 | US20080124312 Using topical skin treatment to combat age-related skin pigmentation, skin elasticity, color and smoothness disorders |
| 05/29/2008 | US20080124311 Novel pharmaceutical compositions for the treatment of virus infection and cancer |
| 05/29/2008 | US20080124310 Bead based receptor biology |
| 05/29/2008 | US20080124309 Cell Surface Glycoprotein |
| 05/29/2008 | US20080124307 Method for promoting immunotherapy |
| 05/29/2008 | US20080124303 Exhibits tubercin activity; immune enhancers such as glycyrrhizin (GR), glycyrrhetic acid, and Chinese herbal extracts |
| 05/29/2008 | US20080124302 Modified cytokine for use in treatment and prevention of viral and cell proliferative disorders |
| 05/29/2008 | US20080124301 Oligonucleotide for use in prevention and treatment of cell proliferative and nervous system disorders; antisense agents |
| 05/29/2008 | US20080124299 prophylaxis of liver disorders caused by hepatitis virus by administering interleukins or conjugated interleukins to mammals; viricides |
| 05/29/2008 | US20080124297 Hydrolytically cleaving a plurality of peptide bonds in an allergenic polypeptide, using enzymes to denature all allergens; treating asthma, allergic rhinitis and atopic eczema in both humans and animals |
| 05/29/2008 | US20080124284 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with Porphyromonas gingivalis |
| 05/29/2008 | US20080124280 Thyroid Hormone Analogs and Methods of Use |
| 05/29/2008 | US20080124277 Human and Mouse Targeting Peptides Identified by Phage Display |
| 05/29/2008 | DE102006056024A1 Method for determining and standardizing efficacy of new batch of neurotoxins with already standardized batch, involves carrying out rough estimation of activity of new batch depending on available protein quantity |
| 05/29/2008 | DE102006055210A1 Diätisches Lebensmittel mit erhöhter freie Radikale bindender Wirkung Dietary foods with increased free radical binding effect |
| 05/29/2008 | CA2670830A1 Methods of promoting cardiac repair using growth factors fused to heparin binding sequences |
| 05/29/2008 | CA2670446A1 Ilt-2 (liri) variants with increased affinity for mhc class i molecules |
| 05/29/2008 | CA2670372A1 Depsipeptides and their therapeutic use |
| 05/29/2008 | CA2670223A1 Depsipeptides and their therapeutic use |
| 05/29/2008 | CA2670124A1 Poly-tlr antagonist |
| 05/29/2008 | CA2669558A1 Compositions and methods related to toll-like receptor-3 |
| 05/29/2008 | CA2669347A1 Methods for treating pompe disease |
| 05/29/2008 | CA2668640A1 Biomarkers for neurological conditions |
| 05/29/2008 | CA2667802A1 Multiple sclerosis therapy |
| 05/29/2008 | CA2667705A1 Suppression of mitochondrial oxidative stress |
| 05/29/2008 | CA2666814A1 Combination therapy for treatment of viral infections |
| 05/29/2008 | CA2665839A1 Polypeptide ligands for targeting cartilage and methods of use thereof |
| 05/29/2008 | CA2664734A1 Method of drug delivery for bone anabolic protein |
| 05/28/2008 | EP1925667A1 Specific protein of the pancreatic beta cells of the Langerhans' islands and its applications |
| 05/28/2008 | EP1925665A1 Use of non-viral active agents manufactured with a molecular-biological method for treating acne |
| 05/28/2008 | EP1925626A1 Novel multifunctional cytokines |
| 05/28/2008 | EP1925333A1 Intradermal delivery of substances |
| 05/28/2008 | EP1925320A2 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics |
| 05/28/2008 | EP1925318A1 Recombinant modified vaccinia virus Ankara (MVA)-based vaccine for the avian flu |
| 05/28/2008 | EP1925317A1 Stabilised mRNA tumour vaccins |
| 05/28/2008 | EP1925316A2 Compositions for treating vaginal, cervical and uterine epithelial lesions |
| 05/28/2008 | EP1925315A2 Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation |
| 05/28/2008 | EP1925314A1 Pharmaceutical composition with synergistic anticonvulsant effect |
| 05/28/2008 | EP1924595A2 Novel peptides and uses thereof |
| 05/28/2008 | EP1924594A2 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 05/28/2008 | EP1924593A1 Hcv ns3 protease inhibitors |
| 05/28/2008 | EP1924293A1 Composition and method for prevention and treatment of type i diabetes |
| 05/28/2008 | EP1924286A1 Phrophylactic and/or therapeutic method for treatment of autoimmune disease |
| 05/28/2008 | EP1924278A2 A kit of lyophilized thrombin and lyophilized fibrinogen used to compound fibrin membrane, and its application |
| 05/28/2008 | EP1924277A2 Reduction in myocardial infarction size |
| 05/28/2008 | EP1924276A2 Tissue protective peptides and uses thereof |
| 05/28/2008 | EP1924275A2 Thio-containing inhibitors of aminopeptidase p, compositions thereof and method of use |
| 05/28/2008 | EP1924274A1 Modulation of cell fates and activities by phthalazinediones |
| 05/28/2008 | EP1924248A1 Ph sensitive nanoparticle formulation for oral delivery of proteins/peptides |
| 05/28/2008 | EP1924245A2 Topical formulations of histone deacetylase inhibitors and methods of using the same |
| 05/28/2008 | EP1924160A2 Oral composition for moisturising skin |
| 05/28/2008 | EP1723417A4 C20orf23 as modifier of the igfr pathway and methods of use |
| 05/28/2008 | EP1723415A4 Pdes as modifiers of the igfr pathway and methods of use |
| 05/28/2008 | EP1641820B1 Rasgap derived peptide for selectively killing cancer cells |
| 05/28/2008 | EP1592449B1 Sensitizing cells for apoptosis by selectively blocking cytokines |
| 05/28/2008 | EP1549333A4 Compstatin analogs with improved activity |
| 05/28/2008 | EP1537243B1 Method of diagnosing ovarian endometriosis |
| 05/28/2008 | EP1517696B1 Prevention, therapy and prognosis/monitoring in sepsis and septic shock |
| 05/28/2008 | EP1425031B1 Hdl for the treatment of stroke and other ischemic conditions |
| 05/28/2008 | EP1399744B1 Epf receptor assays, compounds and therapeutic compositions |
| 05/28/2008 | EP1395227B1 Methods and compounds for the diagnosis of inflammatory disease and identification of pharmacological agents useful in the treatment of inflammatory disease |
| 05/28/2008 | EP1377251B1 A cell therapy method for the treatment of tumors |
| 05/28/2008 | EP1343476B1 Preparation of large liposomes by infusion into peg |
| 05/28/2008 | EP1326630B1 Use of glp-2 peptides |
| 05/28/2008 | EP1325035B1 Pharmaceutically acceptable starch and manufacturing process thereof |
| 05/28/2008 | EP1313766B1 Coaster, a human coactivator of steroid receptors |
| 05/28/2008 | EP1307582B1 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis |
| 05/28/2008 | EP1301604B1 Substrates and assays for beta-secretase activity |
| 05/28/2008 | EP1297114B1 NUCLEIC ACID MOLECULES ENCODING A PROTEIN INTERACTING WITH Ser/Thr KINASE Akt |